High expression of LC3 in oral squamous cell cancer, esophageal cancer, and melanoma indicated a poor prognosis (Tang et al. 2013), while low expression of LC3 was associated with poor prognosis in hypopharyngeal cancer and renal clear cell cancer (Wang et al. 2013). Here, MAP1LC3A is linked to clear cell renal carcinoma.